论文部分内容阅读
目的研究外用噻吗洛尔用于治疗婴幼儿血管瘤(IH)的临床效果。方法选择2012年5月-2014年5月共90例IH患儿治疗前行相关检查排除禁忌证,通过超声检查分为浅表型(n=40)、深部型(n=20)及混合性(n=30)3组,均采用外用噻吗洛尔治疗,每月复查1次,通过用药前及用药后3个月进行疗效评价,采用Achauer疗效评定法进行分级评定。结果所有治疗患儿均无不良反应发生,浅表型IH治疗后Ⅲ级以上疗效率达82.5%,深部型IH治疗后Ⅲ级以上疗效率为20%,而混合型IH治疗后Ⅲ级以上疗效率为50%,噻吗洛尔治疗浅表型IH疗效明显优于深部型IH(P<0.05)。结论外用噻吗洛尔治疗浅表型IH安全有效。
Objective To study the clinical effect of topical timolol in the treatment of infantile hemangiomas (IH). Methods From May 2012 to May 2014, a total of 90 cases of IH children were excluded from the study. Exclusion contraindications were divided into superficial (n = 40), deep (n = 20) and mixed (n = 30) 3 groups were treated with topical timolol treatment, once a month, through the medication and 3 months after treatment efficacy evaluation, the use of Achauer efficacy rating method for grading. Results No adverse reactions occurred in all children. The effective rate of grade Ⅲ or above after superficial IH treatment was 82.5%, and the effective rate of grade Ⅲ or higher after deep IH treatment was 20%, while the effect of grade Ⅲ or higher after mixed IH treatment The rate of 50%, timolol treatment of superficial IH was significantly better than the deep IH (P <0.05). Conclusion External use of timolol treatment of superficial IH safe and effective.